Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complexes of serum albumin and cis-dichlorodiammineplatinum (II). The role of cysteine 34 as a nucleophilic entering group and evidence for reaction between bound platinum and a second macromolecule.

× No keyword cloud information.

11 in total

Review 1. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors: K Oettl; R E Stauber
Journal: Br J Pharmacol Date: 2007-04-30 Impact factor: 8.739

2. Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II).

Authors: M W Swaim; S V Pizzo
Journal: Biochem J Date: 1988-08-15 Impact factor: 3.857

3. Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management.

Authors: Janaina Fernandes; Gisele Cardoso de Amorim; Tallita Eduarda da Veiga; Jesiel Cardoso; Alberto Cardoso Arruda; Mara Silvia Pinheiro Arruda; Morgana T L Castelo-Branco
Journal: J Biol Inorg Chem Date: 2019-04-27 Impact factor: 3.358

4. Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site.

Authors: S V Pizzo; P A Roche; S R Feldman; S L Gonias
Journal: Biochem J Date: 1986-08-15 Impact factor: 3.857

5. Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

Authors: F F Farris; F G King; R L Dedrick; C L Litterst
Journal: J Pharmacokinet Biopharm Date: 1985-02

6. Effects of storage on the binding of carboplatin to plasma proteins.

Authors: K Erkmen; M J Egorin; L M Reyno; R Morgan; J H Doroshow
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

7. Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck.

Authors: J D Holding; W E Lindup; C van Laer; G C Vreeburg; V Schilling; J A Wilson; P M Stell
Journal: Br J Clin Pharmacol Date: 1992-01 Impact factor: 4.335

8. Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.

Authors: F G King; R L Dedrick; F F Farris
Journal: J Pharmacokinet Biopharm Date: 1986-04

9. Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor.

Authors: G C Howard; U K Misra; D L DeCamp; S V Pizzo
Journal: J Clin Invest Date: 1996-03-01 Impact factor: 14.808

10. Insonation of Systemically Delivered Cisplatin-Loaded Microbubbles Significantly Attenuates Nephrotoxicity of Chemotherapy in Experimental Models of Head and Neck Cancer.

Authors: Hang-Kang Chen; Shu-Mei Zhang; Junn-Liang Chang; Hsin-Chien Chen; Yi-Chun Lin; Cheng-Ping Shih; Huey-Kang Sytwu; Mei-Cho Fang; Yuan-Yung Lin; Chao-Yin Kuo; Ai-Ho Liao; Yueng-Hsiang Chu; Chih-Hung Wang
Journal: Cancers (Basel) Date: 2018-09-05 Impact factor: 6.639